A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
Highlights from a roundtable featuring cancer survivors and researchers discussing cancer disparities and persistent health inequities.
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the...
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
Highlights from Cancer Today's summer 2024 issue, including treatment-induced heart conditions, profile of Brian Jones, and more.
Learn about the types of cancer immunotherapy including immune checkpoint inhibitors, ACT, therapeutic vaccines, and more.
LGBTQ+ cancer survivors offer lessons learned, and a researcher explains the odds of chronic conditions in LGBTQ+ survivors.
At a recent AACR Special Conference, experts discussed emerging therapeutic options to overcome resistance to Bacillus Calmette-Guérin (BCG).
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.